Role of Khadirashtaka Kwatha in Skin disease(Urticaria)

An Open-Label Randomized Controlled Clinical Study To Evaluate The Efficacy Of Khadirashtaka Kwatha In The Management Of Chronic Urticaria (Sheetapitta) - NIL

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/096895

Enrollment

Registered

2025-11-04

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L508- Other urticaria

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who have fulfilling Diagnostic criteria for Sheetapitta and the international guideline (EAACI/GA2LEN/EDF/WAO) for Chronic Urticaria.x 2. Patients who are willing and able to participate in the study and have Chronic Urticaria, defined as an urticarial eruption for more than 6 weeks duration. 3. Both male and female patients are between the age group of 20 60 years.

Exclusion criteria

Exclusion criteria: 1. Patients who are less than 20 years and more than 60 years in the age group. 2. The disease conditions and medication which will interfere the research output will be excluded. 3. Urticaria less than 6 weeks duration. 4. Drug induced Urticaria. 5. Pregnant and lactating women. 6. Patients with autoimmune diseases like Psoriasis, SLE. 7. Patients having angioedema.

Design outcomes

Primary

Measure	Time frame
Effect of Khadirashtaka Kwatha on Chronic Urticaria ( Sheetapitta)Timepoint: 1st, 2nd, 3rd and 4th week. Follow up on 5th and 6th week	—

Secondary

Measure	Time frame
To improve the Quality of life of the patient (QoL) of Chronic Urticaria (Sheetapitta)Timepoint: 1st week and 6th week	—

Countries

India

Contacts

Public ContactDr Disha Jayeshkumar Sakalshawala

G. J. Patel Institute Of Ayurvedic Studies And Research

soumya.ea@cvmu.edu.in9847003989

Outcome results